Predicting liver tumor recurrence with immediate post-ablation FDG PET/CT

February 26, 2016

Performing PET/CT examinations using the radiotracer 18-Fluoro-deoxyglucose (FDG) immediately following localized liver tumor ablation is more effective than contrast-enhanced CT for predicting tumor recurrence, according to results of a study published online in The Journal of Nuclear Medicine.

Previous studies have shown that FDG PET/CT is an effective tool for assessing treatment success or failure involving liver tumor ablation procedures when performed after a period of about three months.

However, its ability to do so prior to that window of time is confounded by inflammation at the point of ablation, said lead author Francois Cornelis, MD, and his colleagues from Memorial Sloan Kettering Cancer Center in New York City.

Read the full article.